Menu
← Oncology Approval Tracker
FDA DECISION ·
Thalidomide capsules 150 mg
thalidomide · Natco Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Final approval of the first generic 150 mg capsule for labeled use with dexamethasone in newly diagnosed multiple myeloma. The other strengths in the same action received tentative approval.
LAMPGEN ANALYSIS
Why it matters
This action established the first finally approved Natco strength while other strengths awaited final approval.
What research teams should watch
Check capsule strength and the required REMS process. Keep the 2023 decision separate from the later approval of additional strengths.
PRIMARY RECORDS